TargetTab™ has passed successful pre-clinical animal studies and is moving towards human studies within the year.
TargetTab™ communicates with patients’ mobile devices with no onboard batteries and includes proprietary smart polymer technology for the actuation/release system.
TargetTab™ will give people the ability to precisely deliver medication in the right place at the right time, transforming medicine and personalizing delivery for patients.
TargetTab™ expands what is possible for the delivery of therapeutics. The patients can monitor the capsule and release it when and where they need it most.
TargetTab™ interfaces with custom and current wearable and monitoring technology to interact with Learning Artificial Intelligence (AI) Healthcare Systems and the Internet of Medical Things (IoMT).
TargetTab™ can deliver any powdered pharmaceutical that is normally provided in dissolvable capsules. It provides real-time data on the capsule's location and ingestion, can integrate with IoMT to provide critical efficacy and adherence metrics, and reduces adverse outcomes and/or toxicity often prevalent with non-targeted drug delivery for chronic diseases such as Crohn's Disease and colon cancer. With this solution, active ingredients can be delivered to precise, targeted locations within the body and at precise times – cost effectively.